BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Emerging Biotech

DIFF Biotech Secures China Clinical Approval For First Domestic Nasal Spray Influenza Vaccine

Zhejiang Difference Biological Technology Co., Ltd. (DIFF Biotech) announced that its proprietary nasal spray influenza attenuated live vaccine, DIFF-flu, ...

February 10, 2026 | News

Delonix Bioworks Secures China IND Clearance For MenB Vaccine Candidate DX 104

Delonix Bioworks, a clinical-stage biotechnology company developing next-generation bacterial vaccines, recently announced that its Group B...

February 09, 2026 | News

Samsung Biologics PCF System Validated Against Global Carbon Accounting Standards

Samsung Biologics' PCF system validated in line with globally established ISO and PAS standards Validation reflects continued efforts to establish ...

February 09, 2026 | News

Korean Courts Uphold Kolmar Korea Victory In Sunscreen Technology Misappropriation Case

- Korean courts order Intercos Korea to bear full legal costs, affirming both civil and criminal liability Kolmar Korea has secured a decisive legal ...

February 09, 2026 | News

SanegeneBio Licenses RNAi Programme To Genentech In Global Deal Valued Up To USD 1.7 Billion

SanegeneBio grants exclusive worldwide license to one of its RNAi programs to Genentech - SanegeneBio to receive $200 million up...

February 04, 2026 | News

Monash Innovation Labs And Agilent Technologies Australia Deepen Applied Research Partnership

Monash Innovation Labs and Agilent Technologies Australia have formalised a new partnership to embed advanced analytical instrumentation wit...

February 03, 2026 | News

Frontage Laboratories Expands Early Phase Clinical Research Capabilities Across The United States And China

Frontage Laboratories, Inc. ("Frontage"), a global Contract Research, Development and Manufacturing Organization (CRDMO), announced the expansion of ...

February 03, 2026 | News

Azenta Life Sciences Expands Low DNA Binding Consumables To Support Sensitive NGS Workflows

Azenta Life Sciences offers a range of low binding consumables that deliver consistent performance from sensitive applications tha...

February 02, 2026 | News

Simcere Pharmaceutical Group Licenses First In Class TL1A IL23p19 Bispecific Antibody To Boehringer Ingelheim For Inflammatory Bowel Disease

Novel TL1A/IL23p19 bispecific antibody targets drivers of disease pathogenesis to overcome the efficacy ceiling in inflammatory bowel disease. Lice...

January 29, 2026 | News

Kazia Therapeutics Reports Encouraging Early Responses For Paxalisib Combination In Advanced Triple Negative Breast Cancer

Kazia Therapeutics provided a clinical update from its ongoing Phase 1b study evaluating paxalisib in combination with pembrolizumab and chemothe...

January 29, 2026 | News

Skyhawk Therapeutics Reports Positive Nine Month Interim Data For SKY 0515 In Huntington’s Disease

Nine-month findings show mean improvement in Composite Unified Huntington's Disease Rating Scale from baseline of +0.64 points, compared to natural hi...

January 29, 2026 | News

Ellipses Pharma Limited In Licences First In Class B7H3 Targeted ADC From Innolake Biopharm Co. Ltd To Expand Global Oncology Pipeline

Ellipses Pharma Limited (“Ellipses”), a clinical-stage oncology drug development company with a pipeline of innovative programmes, announced th...

January 26, 2026 | News

Gene Solutions And Pangea Laboratory Partner To Advance US Clinical Validation Of Liquid Biopsy Tests

Gene Solutions, a global biotechnology company, and Pangea Laboratory, a CLIA-certified, CAP-accredited Next Generation Sequencing (NGS) leader ...

January 22, 2026 | News

Alteogen Signs Exclusive Global Licensing Deal With GSK Subsidiary Tesaro For ALT B4

Alteogen Inc. (KOSDAQ: 196170) announced that the company has entered into an exclusive license agreement with Tesaro, Inc., a subsidiary of GSK...

January 21, 2026 | News

Stay Connected